Clinical analysis explores anticoagulant therapy's role on recanalization in necrotizing pancreatitis, indicating limited effectiveness.
Clinical course of necrotizing pancreatitis is a dynamic and complex process and SVT is strongly associated with both the severity and persistence of inflammation. Recanalization primarily depends on the resolution of inflammation, and therapeutic-dose anticoagulant therapy does not appear to provide significant benefit. Diabetes mellitus negatively affects recanalization outcomes. Total occlusion makes recanalization more difficult.
No takes yet. Share an insight, caveat, or question.
Çelik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: